1. MET amplification has emerged as a potential biomarker of the clear cell tumor subtype. 2. Clear cell renal carcinoma : del 9p and del 14q are poor prognostic indicators.3. Mutations are especially prevalent in clear cell renal cell carcinoma. 4. Rarely, it is associated with clear cell renal cell carcinoma and papillary renal cell carcinoma. 5. The same translocation is seen in clear cell sarcoma. 6. Neurocytomas were probably historically misdiagnosed as intraventricular oligondedronglioma or clear cell ependymoma prior to this. 7. Clear-cell adenocarcinomas are histopathologically similar to other clear cell carcinomas, with clear cells and hobnail cells. 8. Clear-cell adenocarcinomas are histopathologically similar to other clear cell carcinomas, with clear cells and hobnail cells. 9. Also called clear cell adenocarcinoma and mesonephroma ." 10. However, there are also data in clear cell carcinoma, melanoma and breast cancer showing favorable prognosis.
Mobile